Latest news, Events and Press Releases

Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending.

Please direct any media inquiries to Camilla Campbell, VP Communications at camilla.campbell@curiumpharma.com.

News Press releases Events Publications

Curium’s Mon-Tek Mo/Tc-99m Generator Recognised by the German Design Award 2026

17th November 2025

Curium Announces First Commercial Doses of diagnostic radiopharmaceuticals in Czech Republic and Slovakia for Patients with Prostate Cancer

6th November 2025

Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan

15th October 2025

Newcastle & Oxford Set To Benefit From New Technology to Diagnose Disease

8th October 2025

Curium and NRG PALLAS extend collaboration in the supply of essential medical isotope to hospitals

21st May 2025

Curium receives marketing authorization in Switzerland for PYLCLARI® – an innovative 18F-PSMA PET tracer indicated in patients with prostate cancer

12th May 2025

Curium enhances its PET manufacturing capacity and expands European footprint with the acquisition of Nucleis

10th April 2025

Curium Announces Approval of Generic DTPA – Kit for the Preparation of Technetium Tc 99m Pentetate Injection in the U.S.

2nd April 2025

Curium completes the acquisition of Monrol as part of its plan to significantly expand Lutetium-177 capacity and PET footprint

28th March 2025

Curium Expands European Supply of Iodine-131 Diagnostic Capsules with New Partnership Agreement with Izotop

30th January 2025

Curium Further Expands European Availability of Pylclari® – an Innovative 18F-PSMA PET Radiopharmaceutical Indicated in Patients With Prostate Cancer

28th January 2025

Curium Completes Enrollment Early of Phase 3 SOLAR-RECUR Prostate Cancer Trial

19th November 2024

1 2 3 4 … 10